MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617074494 A) filed by Pephexia Therapeutics Aps on June 16, 2026, for Selective Npy5r Agonists With High Chemical And Metabolic Stability.
Inventors include Fosgerau, Keld; and Pedersen, Sren Ljungberg.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to NPY5R agonists with high metabolic and chemical stability as well as their use in the treatment of cachexia or anorexia.
Disclaimer: Curated by HT Syndication.
